GQG-18105-30002
4 vaccinations
6 coded responses
37 check-ins
5 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 522 / IA
- Registered
- 2021-01-26
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-04
Dose 1 — Pfizer-BioNTech
-
2021-01-26
Registered in v-safe
-
2021-01-26
Dose 2 — Pfizer-BioNTech
-
2021-01-26
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-01-27
Survey response — days 1–6 daily, dose 2MedDRA: Decreased appetite — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to workFree text: Decreased appetiteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-28
- 2021-01-29
- 2021-01-30
- 2021-01-31
- 2021-02-01
- 2021-02-02
- 2021-02-09
- 2021-02-16
- 2021-02-23
- 2021-03-02
- 2021-03-09
- 2021-04-27
- 2021-07-27
-
2021-10-04
Dose 3 — Pfizer-BioNTech
- 2021-10-04
-
2021-10-05
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend schoolAdult check-in
- 2021-10-06
- 2021-10-07
- 2021-10-08
- 2021-10-09
- 2021-10-10
- 2021-10-11
-
2021-10-18
Survey response — day 14, dose 3MedDRA: Menstruation irregular — Feeling: GoodFree text: Period started two weeks early. Baseline is very regular.MedDRA releases: 2024-11 · check-in free text available
- 2021-10-25
-
2021-11-01
Survey response — day 28, dose 3MedDRA: Nasopharyngitis, Sinusitis — Feeling: Fair · Be unable to work or attend schoolFree text: Sinus infection/coldMedDRA releases: 2024-11 · check-in free text available
-
2021-11-08
Survey response — day 35, dose 3MedDRA: Sinusitis — Feeling: Fair · Be unable to work or attend schoolFree text: Sinus infectionMedDRA releases: 2024-11 · check-in free text available
- 2021-11-15
-
2022-01-03
Survey response — 3 months, dose 3MedDRA: Cholecystectomy — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: CholecystectomyMedDRA releases: 2024-11 · check-in free text available
- 2022-04-04
- 2022-10-04
-
2022-11-21
Dose 4 — Pfizer-BioNTech
- 2022-12-12
- 2022-12-19
- 2022-12-26
- 2023-01-02
- 2023-02-20
- 2023-05-22
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-04 | Pfizer-BioNTech | |
| 2 | 2021-01-26 | Pfizer-BioNTech | |
| 3 | 2021-10-04 | Pfizer-BioNTech | No |
| 4 | 2022-11-21 | Pfizer-BioNTech | No |
Free text
Release 2 — days 1–6 daily, dose 2
Systemic reaction (other): Decreased appetite
Release 10 — day 14, dose 3
Symptoms: Period started two weeks early. Baseline is very regular.
Release 10 — day 28, dose 3
Symptoms: Sinus infection/cold
Release 10 — day 35, dose 3
Symptoms: Sinus infection
Release 10 — 3 months, dose 3
Symptoms: Cholecystectomy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cholecystectomy | · | · | ✓ |
| SD | Foetal death | · | · | ✓ |
| SD | Menstruation irregular | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Sinusitis | · | · | ✓ |
| SRO | Decreased appetite | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release